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CORTISONE which counteracted local growth of a transplanted non-meta-
stasizing adenocarcinoma in mice stimulated production of metastases of the
same tumour (Agosin et al., 1952). The finding of the Chilean group has been
corroborated in work with other transplantable adenocarcinomata (Baserga
and Shubik, 1954; Molamut, Spain, Gault and Kreisler, 1952). In the work with
the transplantable Krebs-II adenocarcinoma cortisone produced widespread
metastases beyond the lung filter, but no such result was obtained with Sarcoma
37 (Pomeroy, 1954). Likewise, cortisone did not affect the incidence, time of
appearance or dclistribution of the anatomic sites of metastases of other trans-
plantable tumours (Kaliss, Borges and Day, 1954; Martinez and Bittner, 1955).
It seemed of considerable interest to study the question whether cortisone may
stimulate production of metastases of a tumour not transplanted but originating
in the body under certain experimental conditions as in the hormonal imbalance
established with intrasplenic ovarian grafts. As known from the work of Biskind
and Biskind (1944) with rats, of Li and Gardner (1947) and many others with
mice, and ofour group with guinea-pigs (Lipschutz etal., 1946; Iglesias, Mardones
and Lipschutz, 1953; Mardones, Iglesias and Lipschutz, 1955) granulosa cell
tumours, luteomata or mixed tumours originate under these experimental
conditions (literature of work with the different species see Lipschutz, 1956).
These tumours produce metastases which occur in mice (Furth and Sobel, 1947;
Li, 1948) but are seemingly very rare in the rat and have been seen only once in
the guinea-pig (Mardones, Iglesias and Lipschutz, 1955), almost five years after
transplantation. In mice metastases occur sooner than that; but in the strains
with which we shall deal in the present paper metastases in the liver have never
been found earlier than 404 days after transplantation. All these statements
recommend the intrasplenic ovarian tumour as very suitable for the study of
the influence cortisone may exert on production ofmetastases of tumours origina-
ting under experimental conditions.
Two strains kept in this laboratory have been used in the present work:
C57bl and Balb A. Both were brought from the United States, kept for several
years in the Institute of General Biology ofthe School ofMedicine and from there
they wereintroducedseveralyears agointoourInstitute. Operationwasperformed
at the age of 32 to 120 days in females and at 43 to 76 days in males of C57bl;
age at operation varied in Balb A between 36 and 111 days. But age at operation
was always uniform in the two comparative cortisone and non-cortisone groups.
The animals were ovariectomized and one of the two ovaries, cut into variousELVIRA MARDONES AND A. LIPSCHUTZ
pieces, was grafted into the spleen. The second ovary was grafted into the spleen
of castrated males of the same litter or the same strain. About six months after
grafting 2 or 4 pellets containing 40 per cent of cortisone acetate mixed with 60
per cent of cholesterol were implanted beneath the skin. The animals were
necropsied 9 to 12 months after grafting the ovary and 3 to 6 months after the
action of cortisone had begun. At necropsy three dimensions of the graft were
measured with callipers; the product is given as the "size " ofthe growth. These
figures are quoted only to indicate the differences obtained in the various
comparative groups of animals; they are stultified by the fact that at necropsy
cysts, large and small, mostly haemorrhagic, are unavoidably measured as part
of the growth. A more exact comparison of size attained has been reached in
another way which will be mentioned later. At necropsy a careful search was
made for metastases, especially in the liver andlungs.
RESULTS
Metastases
We had at our disposal 55 animals not receiving cortisone in which ovarian
tumours were produced, and 37 animals receiving cortisone in which ovarian
tumours though of lesser size were found (Table II). In none of these 92 animals
with ovarian tumours were hepatic metastases present at necropsy performed
302 to 407 days after grafting the ovary into the spleen.
Tiny nodules were found in the lung, especially at or near the pleura, in some
oftheseanimals, with greater incidence in Balb A. The nodules were as frequent
in animals without as with cortisone. At microscopical examination the nodules
appeared in some cases very suspect of being metastases of granulosa-cell
tumours. But similar nodules are known to appear in the lung of mice spon-
taneously (Shimkin, 1955).
Absorption of cortisone was of 30 to 90/ug./day, during 4 to 6 months (Table
I). Production ofmetastases, as evident from the present work, was not stimulated
by the continuous absorption of these quantities of cortisone acetate. Absorption
of the corticoid was calculated on the assumption of non-selective absorption
(Fuenzalida, 1950; Fuenzalida and Lipschutz, 1953); should this assumption be
wrong, the quantities ofcortisone absorbedper daywould be two and a halftimes
those given above.
Metastases were found in the liver in 4 animals of strain Balb A not belonging
to the groups classified in Tables I and II. Two of these animals were females
which died at 404 and 431 days after grafting the ovary into the spleen; 2 were
males which died at 540 and 570 days. In all the 4 cases the ovarian growths
were granulosa-cell tumours. None of these animals had received cortisone.
No metastases were found so far in any animal of the C57bl strain dying at
309 to 644 days.
Growth of the intrasplenic ovarian tumour
Full evidence was produced in our work that cortisone deeply interferes in
the growth of theintrasplenic ovarian tumour. Results obtained are classified in
Tables I and II.
There was a total of 66 animals not receiving cortisone. The ovary took in
57 animals (Table II); no remains ofthe ovarian graft were foundintheremaining
9 animals. No less than 55 out of 57 animals with successful ovarian grafts had
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ovarian tumours. In other words: when the ovary had taken in the spleen
ofthese castrated females or males it was transformed into a tumour in more than
96 per cent ofthe cases. These results are fully in agreement with those of other
authorities (Klein, 1953).
TABLE I.-95 Animals with Intrasplenic Ovarian Grafts, 9 to 13 Months
After Grafting.
(2)
No. of
ani-
mals.
(3)
Duration
total
days.
19 305-377
13 302-374
(4)
Duration
cortisone
days.
(5)
Cortisone
mg./day.
(6)
"Size "§
ofgrowth
average
(cm.3).
(7)
Signi-
ficant
differeno
a.
0 0 1-954±0*5 V 2·0 119-180* 31-76 0 57±0 44
III Male 9 315-378 0 0 169±06 16 IV ,, 12 313-377 122-180** 30-84t 0-53±i0 29
13 334-407 0 0 1 00+0 6
8 331-372 121-203 41-94tt 0*04+0-01
(8)
Minimum
and
e maximum
size (cm.3).
0 020-7 34
{ 008-5-83
0-220-5'67
0 003-3-36
0-001-7-29
0*008-0* 13
VII Male 13 267-384 0 0 0·56+0'151 20 O- 100-2 03
VIII ,, 8 267-374 82-164 50-58ttt 0-14:±003f ' 0-080-0.26
* One animal 66 days only. ** Three animals 41, 89 and 92 days only.
t Two animals with 102 and 121 [g./day. tt One animal with 113 [Lg./day. ttt One animal
with 21 {Lg./day.
§ "Size" of growth: product of three dimensions as measured by callipers at necropsy, in
centimetres.
TABLE II.-107 Animals with Intrasplenic Ovarian Grafts.
(12 animals included which were ommitted in Table I on account of very
large cysts).
Strain
and
sex.
C57bl
I . Female
II . ,,
III . Male
IV . ,,
Balb A
V Female .
VI . ,,
VII . Male
VIII . ,,
(3)
With
(2) gran.
(1) Number c.t., or
Cortis. total. mixed.'
(4)
With
luteoma,
or
mixed.2
(5)
Signs of
degenera-
tion.3
0 . 20 . 15 . 5 . 0
+ . 20 . 2 . 8 . 6 (5)
0 . 10 . 8 . 2 . 0
+ 12 . 4* . 1 . 5 (4)
0 . 14 . 6 7 . (1**)
+ . 8 . 1 . 3 . 0
0 . 13 . 3 . 9 . 0
+ . 10 . 2 . 4 . 1
Luteo-
matous
(6) reaction.
No
tumour or (7) (8)
doubtful.8 Num-. %.
ber.4
0 . 5 25
4 (3) . 16 80
0
2 (2)
1 (1)
4 (4)
2 20
7 58
8 57 ·7 88
1 (1) . 10 77
3 (3) . 7 70
1 Granulosa-cell tumour, or mixed tumours but granulosa-cell nodules predominating.
2 Luteomata, or mixed tumours but luteomatous tissue predominating.
3 Refers only to animals in which ovarian structures were present.
( ) Animals with cords or nodules of lutein cells, often degenerated.
Sum of colum (4) and ( ) of columns (5) and (6).
* Two very small ones.
** Partial degeneration of 1 of granulosa-cell tumours.
(1)
Strain
and
sex.
C57bl
I Female
II ,,
Balb A
V Female
VI ,,
519ELVIRA MARDONES AND A. LIPSCHUTZ
Taking of the ovary in animals receiving cortisone was as frequent as without
cortisone. No remains of the ovary were found in 3 out of 53 animals receiving
cortisone. But in 13 out of the total of 50 cases in which the ovary had taken,
ovarian tumours were absent; or, to be more explicit, we did not feel sure whether
these tiny structures consisting of cords or nodules of lutein cells around follicular
cysts still deserved to be classified as "tumours ". We shall deal more fully with
this question in the next section.
The fundamental influence cortisone exerted onthe evolution ofthe intrasplenic
ovarian tumour was fully evident at necropsy and especially when tabulating
results obtained by measuring with callipers the size of the grafts or more
exactly, whatseemed to beintrasplenicgrowths. The growths appearedtobe smaller
in the 4 cortisone groups than in the 4 corresponding groups without cortisone.
However, the size of the growths varied enormously in all the groups. Thus, the
first feeling was one of bewilderment. But when calculating the averages it was
again found that the growths were smaller in all the 4 groups with cortisone than
in the corresponding groups without cortisone. Since many of these grafts
contained large cysts (compare Fig. 1,2 and 3) it was thought that cysts might have
stultified the results oftabulation. To avoid this error, animals in which the grafts
contained large cysts, occupying more than half of the cut surface, as for instance
Fig. 3, were omitted. Thus, only 95 out of 107 animals have been used for final
tabulation (Table I). The results were again clear cut; the average size of the grafts
was, in the 4 cortisone groups, without any exception, considerably smaller than
in the 4 corresponding groups without cortisone (see Column 6) notwithstanding
the enormous variation in size in the groups themselves (Column 8). This explains
why the significant difference (o-) between the non-cortisone and the cortisone
groups was poor, not attaining even 2 inIII/IV and V/VI (Table I).
EXPLANATION OF PLATES
FIG. 1.-Tumour of non-cortisone female C57bl (61). Solid granulosa-cell tumour, without
cysts. A 3.
FIG. 2.-Tumour of non-cortisone female C57bl (61a). Predominantly granulosa-cell.
Note large cysts. Omitted in Table I. x 3.
FIG. 3.-Tumour of non-cortisone female C57bl (17). Predominantly granulosa-cell; 1-luteoma-
tous tissue. A haemorrhagicfollicle also was present. Note large space occupied by loose
connective tissue. x 3.
FIG. 4.-Largest tumour of non-cortisone females C57bl (65).
X 3. (See also Fig. 9 and 10.)
FIG. 5.-Largest tumour of cortisone females C57bl (60). x 3. (See also Fig. 12.)
FIG. 8.-Alm ost solid part of predominantly granulosa-cell tumour of non-cortisone female
C57bl (62). X 263.
FIG. 9.-Part of granulosa-cell tumour of Fig. 4 (65). Massive cords. X 263.
FIG. 10.-Part of the same granulosa-cell tumour (65). Annular disposition of cells. x 263.
FIG. 11.-Mixed tumour, predominantly luteoma; non-cortisone female (41). x 270.
FIG. 12.-Granulosa-cell tumour of cortisone female (60). (Same animal as Fig. 5.) x 270.
FIG. 13.-Mixed tumour, predominantly luteoma. Cortisone female (43). Part of the lutein
cells greatly increased and hyalinized. x 270.
FIG. 14.-Small luteoma of cortisone female (39) on the surface of the spleen. Bottom-two
lutein cysts; top-nodule of luteinized cells. x 10.
FIG. 15.-Small luteomatous nodule of cortisone female (38). Classified as non-tumourous or
doubtful (Column 6, Table II). Bottom-lutein cysts and lutein cords; top -spleen with
small cyst and lutein cords completely surrounded by the parenchyma of the spleen. Picture
typical of the guinea-pig at about 6 to 10 months after grafting. x 37.
FIG. 16.-Wall of lutein cyst of Fig. 15. Lutein cells mostly degenerated. x 104.
FIG. 17.-Degenerated luteoma of cortisone female (15). Top-spleen; bottom-leucocytic
infiltration. x 36.
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Fi. 6. Surface occupied by granulosa-cell and luteomatous tissues in the microscopical
slides of 20 non-cortisone females of C57bl (Group I in Table II). Cysts always omitted.
G = granulosa-cell tumour; Gm = mixed tumour but granulosa-cell tissue predominating ;
L = luteoma; Lm = mixed tumour but luteomatous tissue predominating.
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FIG. 7.-Surface occupied by the ovarian growth of 16 cortisone females of C57bl (Group II iln
Table II); 4 non-tumourous grafts have been omitted. D = degenerated.
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There was another striking difference between the cortisone and non-cortisone
groups: notwithstanding the bewildering variation in the size of the growth,
maximal size was invariably smaller in the cortisone group than in the non-
cortisone groups (Table I, Column 8: Fig. 4 and 5).
Of fundamental importance is also the fact already mentioned above, and
to be discussed more fully in the next section, that several tiny grafts in
the cortisone groups, especiallyin the Balb A strain, scarcely deserved to be classed
.as tumoural.
To avoid the error in the evaluation of the comparative size of the growths
due to cysts the following procedure was adopted. The preparations of the 40
animals of Groups I and II (Table II) were photographed at x 3. The surface
occupied by tumourous tissue (granulosa-cell andluteomatous) was then delineated
with the control ofthe microscope (Fig. 6 and 7). The relation ofthe total surface
of the tumourous tissue in the non-cortisone and cortisone Groups I and II was
of 100: 16.
Before proceeding to comparative microscopical observations in the cortisone
and non-cortisone groups two interesting facts may be mentioned: the evolution
of the ovarian tumour differed, apparently, according to the sex of the host and,
certainly, according to the strain.
As seenfrom Column 6of Table I the average size of the growths in the non-
cortisone groups was greater in females than in males (compare I/III and V/VII).
Also the maximal size attainedinthefemales ofthenon-cortisonegroups waslarger
than in males; this rule does not apply to those groups in which the evolution of
the tumour was interfered with by cortisone (II/IV and VI/VIII). However,
when discussing the comparative growth of the ovarian tumour in both sexes one
-must not overlook the fact that we are dealing with ovarian autografts in females
and with homografts in males. There is also the conflicting fact that in the work
of Klein (1953)theincidence of intrasplenic ovarian tumours was even higher in
males than in females!
Quite different is the situation when dealing with strain differences. The strain
differences between C57bl and Balb A become fully evident when comparing
averages in I/V and III/VII. Indeed, as already insisted upon, the notion of
the average "size" of these experimental tumours is a very inexact one on
account of the heterogeneous structure of the tumours and on account of the
bewildering individual variations. But the existence of strain differences in the
growth of the tumour becomes more evident when considering the microscopical
structure of the tumours.
M1icroscopical observations
As known from former work ofthe authorities the intrasplenic ovarian growth
in mice is predominantly agranulosa-cell tumour (Fig. 8, 9, 10, 12). But thegrowth
may contain also luteinized tissue (Fig. 11, 13) or may be a pure luteoma (Fig. 14).
We have classified the microscopical results in Table II according to the following
rules: pure granulosa-cell tumours were pooled together with mixed tumours in
which granulosa-cell nodules predominated; pure luteomata which were
rare, were pooled with mixed tumours in which nodules of luteinized cells
predominated. In Groups I and III of Table II an overwhelming number of
non-cortisone animals ofthe C57bl strain hadgranulosa-cell tumours, or tumoursin
which granulosa-cell nodules predominated; no less than 23 out of 30 tumours
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(77 per cent) consisted predominantly of granulosa-cells. On the contrary, in
the Balb A strain granulosa-cell nodules predominated in only 9 out of 25 (36
per cent) non-cortisone animals with tumours (V/VII).
The last statement acquires considerable interest in view of the fact that the
species difference to which attention has been attracted in former work, that of
mice and guinea-pigs, manifests itself in the same evolutional trend. The intra-
splenic ovarian tumour in the guinea-pigis, in the course ofthe first years, luteoma
(Lipschutz et al., 1946; Iglesias, Mardones and Lipschutz, 1953): the appearance
of the granulosa-cell tumour is a very late phenomenon (Mardones, Iglesias and
Lipschutz, 1955). Likewise, as already insisted upon, the incidence of luteomata
was considerably greater among the ovarian tumours in strain Balb A growing
more slowly than in strain C57bl.
In view of these comparative findings it is very remarkable that the inhibitory
action of cortisone which expresses itself in the smaller size of the tumour, is
paralleled by a greatly diminished incidence of granulosa-cell tumours. This
diminution was fully evident in I/11,III/IV and V/VI, but not in males Balb A
VII/VIII in which the incidence of granulosa-cell tumours was already small in
the non-cortisone group.
Theslowing down oftumourgrowthmanifestsitselfalso inthe greaterincidence
of animals in which there is no tumour at all, or in which disorderly growing
lutein tissue does not reach a degree which would allow one to designate the tiny
strands or nodules of lutein cells present as growths or tumours (Column 6 of
Table II; Fig. 15 and 16). Thus, there were, among the 50 animals with cortisone,
no less than 13 animals, or 26per cent, in which it wouldhave seemedpreposterous,
or say too liberal, to speak of luteomata. On the contrary, among the 57 non-
cortisone animals there were only 2 grafts, or about 4 per cent, ofthis type, both
grafts belonging to the Balb A groups (V and VII).
In 11 out of 32 cortisone animals ofthe C57bl strain (II and IV) a pronounced
degeneration and hyalinization of the tumoural tissue took place (Fig. 17; see
also Fig. 13 and 16). In most of these animals the hyalinized cells appeared to
have been originally luteinized. There were necrotic masses, sometimes with
leucocytic infiltration (Fig. 17): or the greater part of the growth was replaced
by loose and oedematous connective tissue. Only one similar case occurred in
the Balb A strain (VIII).
As already insisted upon Table II gives also goodevidence of straindifferences
between C57bl and Balb A; no less than 16 out of 25 non-cortisone animals of
Balb A with tumours (64 per cent; V and VII) had luteomata whereas luteomata
occurred in only 7 out of 30 non-cortisone animals of C57bl with tumours (23
per cent; I and III). This statement is of great interest as there is seemingly not
much difference between various strains as to incidence of tumours in the intra-
splenic ovarian graft as shown also by theworkofKlein (1952, 1953) with various
strains (see also Gardner, 1955). Indeed, one must not overlook that figures
referring to incidence of tumours depend on the arbitrary criterion in classifying
the disorderly grown ovarian tissues as tumourous or non-tumourous.
DISCUSSION
Fullevidenceis offeredthat metastaticspreadofintrasplenic ovariangranulosa-
cell tumours or luteomata was not stimulated by the quantitites of cortisone
acetate we have administered. Indeed, one mayinsist that the quantities absorbed
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from cortisone pellets were smaller than those given in daily injections by the
authorities who have worked with transplanted tumours. However, on the other
hand, one may argue that in our work absorption was a continuous one which
greatly enhances the activity of steriods. This was evidenced also in preliminary
experiments in which pellets of pure cortisone acetate were implanted subcutane-
ously, with an absorption of about 400 ,g. per day. The animals died, without
exception, at about 30 days of cortisone treatment.
In our experiments the action of cortisone acetate was prolonged for 4 to 6
months, without metastases being produced, or better without metastatic spread
being enhanced, since in experiments of longer duration metastases occurred in
non-cortisone animals of one of the strains used.
On the other hand, the quantities of cortisone acetate given in our experiments
which failed to enhance metastatic spread, were sufficient to interfere in a deep-
going manner in the evolution of the ovarian tumour. This makes it all the less
probable that the failure as to metastatic spread was due to insufficient quantities
of cortisone having been administered.
We must now ask in which way cortisone produced inhibition of growth of
the intrasplenic ovarian tumour. At the actual moment no definite statements
can be made as to this. Retardation ofgrowth oftransplantable tumours has been
supposed to be due to a change in the environment of the tumour and more
specifically to the delay in new blood vessel formation (Antopol, Glaubach and
Graff, 1954). In our work the action of cortisone was made to begin only about
4 to 6 months after grafting. There were signs of degeneration in 12 out of 50
animals with cortisone (Table II). This condition can be brought in harmony
with the concept of the inhibitory action of cortisone being localized in the
immediate environment of the tumour. But certain observations would allow
for another explanation which we must discuss here.
One of the outstanding differences between the cortisone and non-cortisone
groups was the considerable diminution of the incidence ofgranulosa-cell tumours
which took place in all groups, with the exception of the Balb A males in which
the incidence of granulosa-cell tumours was already small in the non-cortisone
group. The diminution of incidence of granulosa-cell tumours in C57bl females
under the influence of cortisone was paralleled by an increasedincidence ofanimals
with luteomata plus animals with luteomatous nodules not yet deserving to be
classedastumourous. Most caseswithdegenerationalsobelongedtothe luteomatous
pattern. The same seems to be true for males C57bl where there was only one
animal with luteoma but a large number of animals with degenerated luteomatous
tissue or animals with small luteomatous nodules not classed as tumours. Since
the evolution of the intrasplenic ovarian growth-granulosa-cell tumours or
alternatively luteomata-depends undoubtedly on a specific pattern of the
uncontrolled delivery of hypophysial gonadotrophic hormones one may tenta-
tively suggest that the antitumourigenic action of cortisone was due to an inter-
ference with the production or delivery of these hormones. The ovarian tumoural
constellation in C57bl in which granulosa-cell tumours predominate approaches,
under the influence of cortisone, that of the guinea-pig in which luteomata or
small luteomatous nodules predominate in the first two years aftet grafting.
Column 8 of Table II summarizes the displacement from predominance of the
granulosa-cell tumnour to predominance of the luteomatous reaction. It may be
mentioned here that in our work with the antiluteinizing action of different
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steroids (Mardones, Iglesias and Lipschutz, 1956) cortisone has been found to be
void of any such action (unpublished experiments of Dr. S. Figueroa and others).
All happens as if, in the guinea-pig, a steroid homeostasis different from that
in strain C57bl were responsible for the tumoural evolution of the ovarian graft
characteristic of this species. Thus it would seem that the difference as to ovarian
tumoural evolution between guinea-pig and strain C57bl can be expressed in terms of
a genetically given different pattern of the steroid homeostasis in the mentioned two
species. The same might be true for the smaller differences between strains of
mice as those between females of C57bl and Balb A in our Table II. And cortisone
is not the only steroid which might be in play.* Evolution of tumours in intra-
splenic grafts in mice has been inhibited by oestrogen and androgen (Li and
Gardner, 1949): evolution of luteomata in guinea-pigs has been inhibited by
progesterone (Iglesias, Lipschutz and Mardones, 1950).
The conclusion drawn in our former paper that the difference between mice and
guinea-pigs must be expressed in terms of a differential time of evolution of the
respective type ofmalignant neoplastic growth (Mardones, Iglesias and Lipschutz,
1955) always remains valid. Our suggestion that a genetically given pattern of
steroid homeostasis may be in play here, refers only to one of those mechanisms
by which the differential evolution is effected or interfered with.
The antitumourigenic actionof cortisone, if effected via the hypophysis, would
offer another aspect of great interest. Interference of cortisone, which is a
corticoid, in the production or delivery of gonadotrophic hormones would be a new
and very striking example of the intimate relationship existing between the
various organotrophic functions of the hypophysis ; tumours of the suprarenal
are induced in certain strains of mice or rats by castration, i.e. presumably by
a deficiency of ovarian hormones. Hitherto the organotrophic faculties of the
hypophysis have been considered as the sum of independent gonadotrophic,
thyrotrophic, corticotrophic, somatotrophic or other functions. At first glance
this concept seems to be corroborated by the fact that each of the various organo-
trophic functions and so also their tumourigenic deviations are related to certain
cell types as shown especially by the outstanding experimental work of Furth
(1954) and his colleagues on thyrotrophin- or corticotrophin-secreting pituitary
tumours. But production of suprarenal tumours by castration as known from
classic work ofWoolley and others, and the possibility of controlling the tumouri-
genic deviation of the gonadotrophic function of the hypophysis by cortisone-
should our tentative suggestion beright that cortisone has acted not on the tumour
itself-show that the organotrophic hypophysial potency is an integrated whole
and that different organotrophic functions of the hypophysis are intertwined
in the narrow space ofthe anterior lobe (see also Section 11 in Lipschutz, 1956).
SUMMARY
Cortisone acetate was administered to castrated mice of two different strains
(C'57bl and Balb A) bearing intrasplenic ovarian grafts, to study the question
whether metastatic spread of a tumour growing under the given experimental
conditions could be enhanced by this steroid. Cortisone was allowed to act 4 to
6 months through continuous absorption from subcutaneously implanted pellets.
Metastatic spread was not enhanced in the cortisone animals.
* Neither is cortisone an antitumourigenic steroid per se Survival and proliferation of human
tumiours transplanted into rats is rendered possible by the administration of cortisone (Toolan, 1953).
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The quantities ofcortisoneacetateadministeredgreatly sloweddownthegrowth
of the intrasplenic ovarian tumours in both strains used.
The microscopical structure of the tumours also was fundamentally influenced
by cortisone: the incidence ofgranulosa-cell tumours greatly diminished and the
incidence of luteomata plus luteomatous nodules increased.
The small luteomatous ovarian growths, tumoural or non-tumoural, in the two
strains of mice treated with cortisone were similar to the slowly growing intra-
splenic ovarian growtihs in the guinea-pig in the first two years after grafting.
The tentative suggestion is made that the antitumourigenic action of cortisone
was by interference with the production or delivery ofgonadotrophic hypophysial
hormones on which ovarian tumourigenesis in intrasplenic grafts depends.
If this interpretation were true the results obtained would suggest that
differences as to the evolution ofintrasplenic ovarian tumours between guinea-pigs
and mice, or between different strains ofmice, should be explained by a genetically
determined difference in the pattern of the steroid homeostasis.
The results obtained wouldlikewise offer a new example ofhow a tumourigenic
deviation of the gonadotrophic function of the hypophysis can be influenced by
a corticoid whoseproduction inthe body is dependent on the corticotrophicfunction
of the hypophysis.
Cordial thanks are due especially to Miss Socorro Salinas for generous help at
operations and necropsies, and to Mr. Alejandro Castillo, photographer.
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